Cytokeratin fragment 19 (CYFRA 21-1) and carcinoembryonic antigen for early prediction of recurrence of lung adenocarcinoma

Lung

Volumn 177, Issue 5, 1999, Pages 333-337

  Kao, Chia Hung ^a   Hsieh, J F ^b   Ho, Y J ^b   Ding, H J ^b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Carcinoembryonic antigen; Cytokeratin fragment 19 (CYFRA 21 1); Lung adenocarcinoma

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CANCER RECURRENCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK;

ADENOCARCINOMA; ADULT; AGED; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; KERATINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0032825566     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007651     Document Type: Article

References (18)

1. 1. Bodenmuller H, Banauch D, Ofenloch B, Jaworek D, Dessauer A (1992) Technical evaluation of a new automated tumor marker assay: the enzyme-test CYFRA 21-1. In: R Klapdor (ed) Tumor Associated Antigens, Oncogenes, Receptors, Cytokines in Tumor Diagnosis and Therapy at the Beginning of the 90th. Verlag, Zuckschwerdt, pp 37-138
2. 2. Bodenmuller H, Ofenloch Hahnle B, Lane EB, Dessauer A, Bottger V, Donie F (1994) Lung cancer-associated keratin 19 fragments: development and biochemical characterisation of the new serum assay enzymun-test CYFRA 21-1. Int J Biol Markers 9:75-81
3. 3. Broers JL, Ramaekers FC, Rot MK, Oostendrop T, Huysmans A, van-Muijen GN, Wagenaar SS, Vooijs GP (1988) Cytokertains in different types of human lung as monitored by chain-specific monoclonal antibodies. Cancer Res 48:3221-3229
4. 4. Broers JL, Rot MK, Oostendrop T, Huysmans A, Wagenaar SS, Wiersma-van-Tiburg AJ, Vooijs GP, Ramaekers FC (1987) Immunohistochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal and neuroendocrine antigens. Cancer Res 47:3225-3234
5. 5. Cheah PL, Liam CK, Yap SF, Looi LM (1994) Squamous cell carcinoma antigen as an adjunct tumour marker in primary carcinoma of the lung. J Clin Pathol 47:533-537
6. 6. Concannon JP, Dalbow MH, Hodgson SE, Heading JJ, Markopoulos E, Mitchell J, Cuching WJ, Liebler GA (1978) Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma. Cancer 42:1477-1483
7. 7. Debus E, Moll R, Franke WW, Weber K, Osborn M (1984) Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am J Pathol 114:121-130
8. 8. Habets JM, Tank B, Vuzevski VD, Breve J, Van-der-Kwast T, van-Joost T (1989) Immunoelectron microscopic studies on cytokeratins in human basal cell carcinoma. Anticancer Res 9:65-70
9. 9. Hoefliger M, Morant R, Riesen W, Baumgartner G, Engler H (1994) CYFRA 21-1: initial experiences in bronchus carcinoma and other tumors. Schweiz Med Wochenschr 124:1966-1970
10. 10. Huang MS, Jong SB, Tsai MS, Lin MS, Chong IW, Lin HC, Hwang JJ (1997) Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma. Respir Med 91:135-142
11. 11. Icard P, Regnard JF, Essomba A, Panebianco V, Magdeleinat P, Levasseur P (1994) Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer. Ann Thorac Surg 58:811-814
12. 12. Kasper M, Stosiek P, Typlt H, Karsten U (1987) Histological evaluation of three new monoclonal anti-cytokeratin antibodies. 1. Normal tissues. Eur J Cancer Clin Oncol 23:137-147
13. 13. Koga H, Eguchi K, Shinkai T, Tamura T, Ohe Y, Oshita F, Saijo N, Kondo H, Oki K, Okura H (1994) Preliminary evaluation of the new tumor marker, CYFRA 21-1, in lung cancer patients. Jpn J Clin Oncol 24:263-268
14. 14. Kohno N, Hirasawa Y, Kondo K, Fujioka S, Fujino S, Abe M, Yokoyama A, Hiwada K, Watanabe K, Nishimura J (1997) Comparison studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma. Cancer Detect Prev 21:124-128
15. 15. Lai RS, Hsu HK, Lu JY, Ger LP, Lai NS (1996) CYFRA 21-1 enzyme-linked immunosorbent assay: evaluation as a tumor marker in non-small cell lung cancer. Chest 109:995-1000
16. 16. Spiro SG (1988) Prognosis and end results. In: Hoogastraten B, Addis BJ, Hansen HH, Martini N, Spiro SG (eds) Lung Tumors. Springer-Verlag, Berlin, pp 163-166
17. 17. Stokes TC, Steves JFS, Lockey E, Miller L (1980) Preoperative carcinoembryonic antigen and survival after resection of lung cancer. Br J Dis Chest 74:390-394
18. 18. van-der-Gaast A, Schoenmakers CH, Kok TC, Blijenberg BG, Cornillie F, Splinter TA (1994) Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1. Br J Cancer 69:525-528